IL6 and cystic fibrosis: Gastrointestinal, nervous, and cardiovascular diseases might benefit from chronic anti-inflammatory properties of CF [41], as evidenced by a lowered TNF-α and IL-6 in type 2 diabetes patients following 6 weeks of CF supplementation [42].